Marker Therapeutics (MRKR) Asset Utilization Ratio (2016 - 2025)

Marker Therapeutics (MRKR) has 9 years of Asset Utilization Ratio data on file, last reported at 0.17 in Q4 2025.

• Asset Utilization Ratio for Q4 2025 came in at 0.17, down 61.43% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.17 (down 61.43% YoY), and the FY2025 annual result was 0.17, down 48.73% from the prior year.
• Asset Utilization Ratio retreated to 0.17 in Q4 2025 per MRKR's latest filing, from 0.26 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.55 in Q3 2024 and troughed at 0.02 in Q1 2022.
• A 4-year average of 0.21 and a median of 0.17 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio surged 596.39% in 2023, then tumbled 61.43% in 2025.
• A 4-year view of Asset Utilization Ratio shows it stood at 0.09 in 2022, then surged by 94.42% to 0.18 in 2023, then jumped by 149.2% to 0.45 in 2024, then plunged by 61.43% to 0.17 in 2025.
• Business Quant data shows MRKR's Asset Utilization Ratio at 0.17 in Q4 2025, 0.26 in Q3 2025, and 0.34 in Q2 2025.